CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Cleveland, Ohio, United States and 35 other locations
The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...
Phase 2
Cleveland, Ohio, United States and 17 other locations
participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...
Phase 1, Phase 2
Cleveland, Ohio, United States and 22 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Cleveland, Ohio, United States and 226 other locations
This study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specif ...
Phase 2
Cleveland, Ohio, United States and 5 other locations
(Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor activity of BB-1701 at RD in the selected population(s) of breast...
Phase 2
Cleveland, Ohio, United States and 30 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Cleveland, Ohio, United States and 446 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Cleveland, Ohio, United States and 166 other locations
with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...
Phase 2
Cleveland, Ohio, United States and 42 other locations
evidence-proven optimal management of curable neurologic conditions. Breast cancer is the most common cancer in African-Am...
Cleveland, Ohio, United States
Clinical trials
Research sites
Resources
Legal